Amneal Pharmaceuticals, Inc.: cashflow_financing

Value{"amount": -38535000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2019-01-01 – 2019-09-30
Statuscurrent
EntityAmneal Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-19-041240 · Open the official SEC filing →
Retrieved: 2026-08-19T17:37:43.208613+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001723128/cashflow-financing/2019-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/bc5564fa-6995-41a8-9793-97eb7da830a9

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies